Get started
Author

L. Imperatori

Observed names: L Imperatori, LUCA IMPERATORI, Luca Imperatori
ORCID: 0000-0003-3633-6529
Observed ORCID: 0000-0003-3633-6529
OpenAlex ID: A5044010121
High activity and reduced neurotoxicity of bi-fractionated oxaliplatin plus 5-fluorouracil/leucovorin for elderly patients with advanced colorectal cancer
2005 · R. Mattioli, C. Massacesi, et al. · Annals of Oncology · 53
Advanced colorectal cancer in elderly patients: tolerance and efficacy of leucovorin and fluorouracil bolus plus continuous infusion.
2001 · R Mattioli, P Lippe, et al. · PubMed · 25
Long-survival in responding patients with metastatic breast cancer treated with doxorubicin-docetaxel combination. A multicentre phase II trial.
2004 · R Mattioli, P Lippe, et al. · PubMed · 13
Covid-19 negatively impacted on small oncology surgery but none on major procedures: Regional experience
2021 · Luca D'Ascanio, Gino Latini, et al. · Oral Oncology · 4
Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted
2020 · DAVID ROSSI, PAOLO LIPPE, et al. · In Vivo · 3
PDF
Feasibility single-arm study of a medical device containing Desmodium adscendens and Lithothamnium calcareum combined with chemotherapy in head and neck cancer patients
2018 · Luca Imperatori, Damiano Giardini, et al. · Cancer Management and Research · 2
PDF
Gemcitabine-oxaliplatin combination (GEM-OHP) in metastatic non-small cell lung cancer (NSCLC): Final results of a phase II study
2005 · P. Lippe, P. Mazzanti, et al. · Journal of Clinical Oncology · 2
150 The impact of vinorelbine in elderly (aged > 70 years) with NSCLC: A preliminary report
1997 · R. Mattioli, L. Imperatori, et al. · Lung Cancer · 2
5075 POSTER Non-pegylated Liposomal Doxorubicin (Myocet e) Plus Docetaxel (Taxotere e) (MYTAX), as First-line Chemotherapy (CHT), in Metastatic Breast Cancer (MBC): Results of a Phase II Study
2011 · L. Imperatori, P. Lippe, et al. · European Journal of Cancer · 1
The impact of vinorelblne in elderly (aged >70 years) with NSCLC: A preliminary report
1997 · R. Mattioli, L. Imperatori, et al. · European Journal of Cancer · 1
Covid-19 Negatively Impacted On Small Oncology Surgery But None On Major Procedures: Regional Experience(Head & Neck cancer in COVID-19)
2021 · Luca D’Ascanio, Gino Latini, et al. · Oral Oncology
Gemcitabine in the treatment of advanced non small cell lung cancer in the elderly: preliminary report according to the multi-dimensional evaluation
1999 · R. Mattioli, F. Guidi, et al. · Lung Cancer
Efficacy and safety of vinorelbine in elderly patients (aged > 70 years) with advanced NSCLC
1998 · R Mattioli, L Imperatori, et al. · Lung Cancer
Works count: 15
Citation count: 106
H-index: 4
I10-index: 3
Year
Topic
Type